Company Tonix Pharmaceuticals Holding Corp OTC Bulletin Board
Equities
TNXP
US8902601025
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
07-09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
07-09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,454,345 | 17,158,681 ( 98.31 %) | 0 | 98.31 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+7.03% | 101B | |
+8.42% | 42.18B | |
-13.04% | 32.26B | |
+80.80% | 29.79B | |
-10.92% | 16.06B | |
+1.93% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock
- Company Tonix Pharmaceuticals Holding Corp